MMRGlobal Receives $30 Million Offer for License of Company's Health IT Patent Portfolio

LOS ANGELES, CA--(Marketwire - Dec 7, 2011) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR"), today announced it has received a proposed agreement from Surgery Center Management, LLC ("SCM") (www.surgerycentermgmt.com) to license certain of the Company's Health Information Technology and Personal Health Record patents for a minimum license fee of $30 million plus additional royalties on terms to be negotiated. Although the offer is subject to the signing of a final definitive licensing agreement, it specifically excludes any of MMRGlobal's biotech assets and other related intellectual property on which the Company has spent more than $100 million in development.

Under the terms of the proposed agreement, MMR would issue a limited non-exclusive, non-transferable, sub-licensable license for its proprietary processes pertaining to the Company's portfolio of Health Information Technology patents. This includes various patents covering proprietary uses of MMR's personal and professional Health IT products and services including its MyMedicalRecords.com Personal Health Record product line for patients (www.mmrvideos.com) and the MMRPro electronic document management and imaging system for physicians, small hospitals and surgery centers (www.mmrprovideos.com). The Company cannot guarantee that a final, legally binding agreement will be reached, however, if completed the agreement would include settlement of any potential claims by MMRGlobal against SCM and its affiliates for any past patent infringement.

In addition to holding numerous patents for Health IT applications, which are already being successfully licensed worldwide, the Company controls a portfolio of biotech assets acquired through a reverse merger with Favrille, Inc. in 2009. Favrille spent more than $100 million in development of certain intellectual property that includes biotech patents and patient samples which MMR is working to license to biotech companies, universities and others. The Company has already demonstrated its ability to license these assets to Big Pharma.

Additional information on the Company's products and services can be found at www.mmrtheater.com and www.mmrglobal.com.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (www.mymedicalrecords.com), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, whether or not such statement relates directly to the proposed agreement from Surgery Center Management, LLC or the terms contained therein, and the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk that the Company and Surgery Center Management, LLC will not reach a definitive agreement with respect to the proposed license agreement and any contemplated transactions therein, and even if consummated, the Company cannot guarantee the terms of such agreement, once consummated, will be favorable to the Company and/or its stockholders; the risk the Company's products are not adopted or viewed favorably by the healthcare community; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; financial projections; product integration in physician practices, surgery centers and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations, especially as related to the healthcare industry; future changes in tax legislation and initiatives and exposure to additional tax liabilities; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; current and future litigation; acceptance of the Company's marketing and promotional campaigns; the value of the Company's broadcasting advertising and sponsorships; negotiated milestone payments; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. You are cautioned not to place undue reliance on the forward-looking statements set forth in this press release.